trazodone has been researched along with Kidney Failure, Chronic in 3 studies
Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One frequently reported symptom is insomnia." | 2.94 | Sleep-HD trial: short and long-term effectiveness of existing insomnia therapies for patients undergoing hemodialysis. ( Abad, K; Cukor, D; Heagerty, P; McCurry, SM; Mehrotra, R; Roumelioti, ME; Rue, T; Unruh, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Unruh, M | 1 |
| Cukor, D | 1 |
| Rue, T | 1 |
| Abad, K | 1 |
| Roumelioti, ME | 1 |
| McCurry, SM | 1 |
| Heagerty, P | 1 |
| Mehrotra, R | 1 |
| Doweiko, J | 1 |
| Fogel, BS | 1 |
| Goldberg, RJ | 1 |
| Fukunishi, I | 1 |
| Kitaoka, T | 1 |
| Shirai, T | 1 |
| Kino, K | 1 |
| Kanematsu, E | 1 |
| Sato, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis (Sleep-HD)[NCT03534284] | Phase 3 | 126 participants (Actual) | Interventional | 2018-09-19 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for trazodone and Kidney Failure, Chronic
| Article | Year |
|---|---|
Sleep-HD trial: short and long-term effectiveness of existing insomnia therapies for patients undergoing hemodialysis.
Topics: Anti-Anxiety Agents; Cognitive Behavioral Therapy; Comparative Effectiveness Research; Humans; Kidne | 2020 |
2 other studies available for trazodone and Kidney Failure, Chronic
| Article | Year |
|---|---|
Trazodone and hemodialysis.
Topics: Aged; Depressive Disorder; Humans; Kidney Failure, Chronic; Male; Piperazines; Renal Dialysis; Trazo | 1984 |
A hemodialysis patient with trazodone-induced parkinsonism.
Topics: Antidepressive Agents, Second-Generation; Depression; Humans; Kidney Failure, Chronic; Male; Middle | 2002 |